Literature DB >> 10991608

Leishmania antigen nonspecific binding to avidin in biotin-avidin immunoassays.

S Agudelo, M Portús.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10991608      PMCID： PMC95943          DOI： 10.1128/CDLI.7.4.717-718.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  7 in total

Review 1.  Applications of avidin-biotin technology: literature survey.

Authors:  M Wilchek; E A Bayer
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Avidin-biotin system in enzyme immunoassays.

Authors:  T Ternynck; S Avrameas
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Prevention of nonspecific binding of avidin.

Authors:  R C Duhamel; J S Whitehead
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 4.  Biotin enzymes.

Authors:  H G Wood; R E Barden
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

5.  Free and bound biotin molecules in helminths: a source of artifacts for avidin biotin-based immunoassays.

Authors:  F Romarís; R Iglesias; L O García; J Leiro; M T Santamarina; E Paniagua; F M Ubeira
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

6.  Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.

Authors:  G S Wood; R Warnke
Journal:  J Histochem Cytochem       Date:  1981-10       Impact factor: 2.479

7.  Biotin enrichment in oligodendrocytes in the rat brain.

Authors:  S M LeVine; W B Macklin
Journal:  Brain Res       Date:  1988-03-15       Impact factor: 3.252
  7 in total
  1 in total

1.  Islet expression of the DNA repair enzyme 8-oxoguanosine DNA glycosylase (Ogg1) in human type 2 diabetes.

Authors:  Björn Tyrberg; Kamen A Anachkov; Sergio A Dib; Jessica Wang-Rodriguez; Kun-Ho Yoon; Fred Levine
Journal:  BMC Endocr Disord       Date:  2002-04-25       Impact factor: 2.763
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.